Median Diagnostics Inc
233250
Company Profile
Business description
Median Diagnostics Inc is a Korea based company engaged in the human and animal disease diagnosis business, which falls within the in vitro diagnostics industry. In vitro diagnostic kits are defined as medical devices, reagents, calibrators, specimen containers, and other items that provide information for diagnosing, monitoring, or assessing the suitability of patients or animals by testing specimens such as tissue, blood, or urine in vitro.
Contact
878 Sunhwan-daero
Dongnae-myeon
Gangwon-do
Chuncheon-si200-883
KORT: +82 332440100
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
67
Stocks News & Analysis
stocks
Will undervalued ASX share show progress in results?
Investors will get to see if the new strategy and capital management framework are working.
stocks
10 best US dividend aristocrats to buy now for 2026
These undervalued stocks with economic moats have increased their dividends for 25 consecutive years or more.
stocks
What to expect from the January Fed meeting
Central bankers are likely to hold interest rates steady, but Wall Street is focused on life after Powell.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,230.30 | 71.00 | -0.76% |
| CAC 40 | 8,152.82 | 21.67 | 0.27% |
| DAX 40 | 24,894.44 | 38.64 | -0.15% |
| Dow JONES (US) | 49,003.41 | 408.99 | -0.83% |
| FTSE 100 | 10,207.80 | 58.95 | 0.58% |
| HKSE | 27,454.89 | 327.94 | 1.21% |
| NASDAQ | 23,817.10 | 215.74 | 0.91% |
| Nikkei 225 | 53,038.44 | 295.10 | -0.55% |
| NZX 50 Index | 13,437.88 | 73.00 | -0.54% |
| S&P 500 | 6,978.60 | 28.37 | 0.41% |
| S&P/ASX 200 | 8,911.20 | 63.10 | -0.70% |
| SSE Composite Index | 4,159.06 | 19.16 | 0.46% |